DE

459.16

-1.11%↓

CTAS

206.67

-1.07%↓

CPRT

60.86

-0.52%↓

CSX

27.92

+0.11%↑

PAYX

142.28

-0.78%↓

DE

459.16

-1.11%↓

CTAS

206.67

-1.07%↓

CPRT

60.86

-0.52%↓

CSX

27.92

+0.11%↑

PAYX

142.28

-0.78%↓

DE

459.16

-1.11%↓

CTAS

206.67

-1.07%↓

CPRT

60.86

-0.52%↓

CSX

27.92

+0.11%↑

PAYX

142.28

-0.78%↓

DE

459.16

-1.11%↓

CTAS

206.67

-1.07%↓

CPRT

60.86

-0.52%↓

CSX

27.92

+0.11%↑

PAYX

142.28

-0.78%↓

DE

459.16

-1.11%↓

CTAS

206.67

-1.07%↓

CPRT

60.86

-0.52%↓

CSX

27.92

+0.11%↑

PAYX

142.28

-0.78%↓

Search

Enovis Corp

Abierto

SectorAcciones industriales

35.05 2.76

Resumen

Variación precio

24h

Actual

Mínimo

34.05

Máximo

35.37

Métricas clave

By Trading Economics

Ingresos

-672M

-703M

Ventas

56M

561M

BPA

0.98

Margen de beneficios

-125.353

Empleados

7,367

EBITDA

-602M

-590M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+78.56% upside

Dividendos

By Dow Jones

Próximas Ganancias

8 may 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-782M

1.8B

Apertura anterior

32.29

Cierre anterior

35.05

Enovis Corp Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

7 ene 2025, 23:28 UTC

Principales Movimientos del Mercado

Maplebear Up on S&P MidCap 400 Inclusion

Comparación entre iguales

Cambio de precio

Enovis Corp previsión

Precio Objetivo

By TipRanks

78.56% repunte

Estimación a 12 Meses

Media 62.71 USD  78.56%

Máximo 75 USD

Mínimo 46 USD

De acuerdo con 8 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Enovis Corp Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

8 ratings

7

Comprar

1

Mantener

0

Vender

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Enovis Corp

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.